UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Lamb, CA; Kennedy, NA; Raine, T; Hendy, PA; Smith, PJ; Limdi, JK; Hayee, B; ... Hawthorne, AB; + view all (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 10.1136/gutjnl-2019-318484. (In press). Green open access

[img]
Preview
Text
gutjnl-2019-318484.full.pdf - Published version

Download (7MB) | Preview

Abstract

Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing), paediatricians (British Society of Paediatric Gastroenterology, Hepatology and Nutrition), dietitians (British Dietetic Association), radiologists (British Society of Gastrointestinal and Abdominal Radiology), general practitioners (Primary Care Society for Gastroenterology) and patients (Crohn's and Colitis UK). A systematic review of 88 247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and expert opinion-based recommendations for pharmacological, non-pharmacological and surgical interventions, as well as optimal service delivery in the management of both ulcerative colitis and Crohn's disease. Comprehensive up-to-date guidance is provided regarding indications for, initiation and monitoring of immunosuppressive therapies, nutrition interventions, pre-, peri- and postoperative management, as well as structure and function of the multidisciplinary team and integration between primary and secondary care. Twenty research priorities to inform future clinical management are presented, alongside objective measurement of priority importance, determined by 2379 electronic survey responses from individuals living with ulcerative colitis and Crohn's disease, including patients, their families and friends.

Type: Article
Title: British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/gutjnl-2019-318484
Publisher version: https://doi.org/10.1136/gutjnl-2019-318484
Language: English
Additional information: This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: 5-ASA, 5-aminosalicylate, CMV, Crohn’s disease, CD, JAK, Ulcerative colitis, UC, adalimumab, adherence, adolescent, adult, anaemia, anti-TNF, anti-drug antibodies, antibiotic, antibiotics, azathioprine, biomarker, breastfeeding, budesonide, calprotectin, cancer, care, chemoprevention, ciclosporin, classification, clostridium difficile, cognitive behavioural therapy, CBT, colectomy, colitis, colonoscopy, computerised tomography, CT, corticosteroid, cyclosporine, cytomegalovirus, diagnosis, diet, endoscopic, endoscopy, enema, faecal microbial transplant, fatigue, fetus, fistula, granuloma, guideline, hydrocortisone, ileitis, inflammatory bowel disease, IBD, infliximab, integrin, janus kinase inhibator, magnetic resonance, MR, management, mercaptopurine, mesalazine, methylprednisolone, monitoring, multidisciplinary team, MDT, nutrition, perianal, pouch, pouchitis, prednisolone, pregnancy, primary stress, probiotic, psychology, psychotherapy, self-management, shared care, sigmoidoscopy, smoking, stress, stricture, suppository, surgery, surveillance, telephone clinic, therapeutic drug monitoring, therapy, thiopurine, tofacitinib, tuberculosis, TB, ultrasound, ustekinumab, vaccination, vaccine, vedolizumab, virtual clinic, vitamin D
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Metabolism and Experi Therapeutics
URI: https://discovery.ucl.ac.uk/id/eprint/10083052
Downloads since deposit
4Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item